{"id":418,"date":"2025-02-25T00:00:00","date_gmt":"2025-02-25T00:00:00","guid":{"rendered":"https:\/\/bannviewmedicalpractice.co.uk\/pharmacy\/the-fda-has-given-fast-track-status-to-pyxis-drug-candidate-pyx-201-this-means-that-the-review-and-approval-process-for-this-drug-will-be-accelerated-because-it-shows-promise-in-treating-a-serious\/"},"modified":"2025-02-25T00:00:00","modified_gmt":"2025-02-25T00:00:00","slug":"the-fda-has-given-fast-track-status-to-pyxis-drug-candidate-pyx-201-this-means-that-the-review-and-approval-process-for-this-drug-will-be-accelerated-because-it-shows-promise-in-treating-a-serious","status":"publish","type":"post","link":"https:\/\/bannviewmedicalpractice.co.uk\/pharmacy\/the-fda-has-given-fast-track-status-to-pyxis-drug-candidate-pyx-201-this-means-that-the-review-and-approval-process-for-this-drug-will-be-accelerated-because-it-shows-promise-in-treating-a-serious\/","title":{"rendered":"The FDA has given fast track status to Pyxis&#8217; drug candidate, PYX-201. This means that the review and approval process for this drug will be accelerated because it shows promise in treating a serious condition. This kind of designation is often granted to drugs that could potentially fulfill an unmet medical need. While the specific condition PYX-201 aims to treat wasn&#8217;t mentioned, similar fast-tracked drugs in the past have included names like Keytruda for cancer and Trikafta for cystic fibrosis."},"content":{"rendered":"<p>Two clinical trials are currently looking for participants to test a new cancer treatment called PYX-201. This treatment, developed by Pyxis Oncology, has received fast track approval from the US Food and Drug Administration (FDA). This means the FDA recognizes its potential to address a significant medical need and will help speed up its development.<\/p>\n<p>PYX-201 is designed for adults with a specific type of head and neck cancer that has returned or spread after previous treatments. These previous treatments include platinum-based chemotherapy and a type of drug known as a PD-L antibody. PYX-201 works by targeting a specific protein in the tumor&#8217;s structure called Extradomain-B Fibronectin.<\/p>\n<p>There are two trials underway: <\/p>\n<p>1. PYX-201-101 is testing the treatment on its own in patients with this type of cancer.<br \/>\n2. PYX-201-102 is testing the treatment in combination with another drug called Keytruda (pembrolizumab) in patients with head and neck cancer and other advanced cancers. This trial is part of a collaboration with the pharmaceutical company MSD.<\/p>\n<p>Lara Sullivan, the president and CEO of Pyxis Oncology, stated that the FDA&#8217;s fast track designation is an important step for the company. It acknowledges their potential to meet a significant medical need and will help them bring this treatment to patients more quickly.<\/p>\n<p>In May 2023, Pyxis Oncology also agreed to buy another company, Apexigen, for $16 million.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The therapy is meant for people whose disease got worse after receiving platinum-based chemotherapy. Some common medications in this category include cisplatin and carboplatin.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-418","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/bannviewmedicalpractice.co.uk\/pharmacy\/wp-json\/wp\/v2\/posts\/418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bannviewmedicalpractice.co.uk\/pharmacy\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bannviewmedicalpractice.co.uk\/pharmacy\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bannviewmedicalpractice.co.uk\/pharmacy\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bannviewmedicalpractice.co.uk\/pharmacy\/wp-json\/wp\/v2\/comments?post=418"}],"version-history":[{"count":0,"href":"https:\/\/bannviewmedicalpractice.co.uk\/pharmacy\/wp-json\/wp\/v2\/posts\/418\/revisions"}],"wp:attachment":[{"href":"https:\/\/bannviewmedicalpractice.co.uk\/pharmacy\/wp-json\/wp\/v2\/media?parent=418"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bannviewmedicalpractice.co.uk\/pharmacy\/wp-json\/wp\/v2\/categories?post=418"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bannviewmedicalpractice.co.uk\/pharmacy\/wp-json\/wp\/v2\/tags?post=418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}